Tuesday, March 9, 2021
10:00 -10:40
THE CLINICAL VALUE OF CSF BIOMARKERS– this session is supported by an Educational Grant from Roche

Tuesday, March 9, 2021
10:30 -17:30
COMMON FEATURES OF NEURODEGENERATIVE DISEASE: EXPLORING THE BRAIN-EYE CONNECTION AND BEYOND – this session is supported by an Educational Grant from BrightFocus

Tuesday, March 9, 2021
13:30 -18:20
PROTECTIVE EFFECTS OF INSULIN AND INCRETINS IN AD/PD – this session is supported by an Educational Grant from Kariya Pharmaceuticals

Saturday, March 13, 2021
10:00 -12:00
FTD, ALS, CORTICOBASAL DEGENERATION – this session is supported by an Educational Grant from Worldwide Clinical Trials

Saturday, March 13, 2021
12:00 – 13:30
ABETA TARGETING THERAPIES IN AD 2 – this session is supported by an Educational Grant from Biogen

General Educational Grant supported by Eli Lilly

General Educational Grant supported by Oxford University

Educational Grant for Portal supported by Roche

General Educational Grant supported by Biogen